Baird Capital Exits PharMEDium

Baird Capital has completed the sale of its equity interest in portfolio company PharMEDium through the close of a transaction with Clayton, Dubilier & Rice. 

PharMEDium is a leading provider of outsourced pharmacy compounding services to the hospital market.

Read the full release here.